Hyun-Woo Kim

Dr. Hyun-Woo Kim

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2023 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Open access
HKHyun-Woo Kim
Hyun-Woo Kim
DSDong-Hyeon Shin
Dong-Hyeon Shin
JKJiyoung Kim
Jiyoung Kim
GLGha-Hyun Lee
Gha-Hyun Lee
JCJae Wook Cho
Jae Wook Cho
Epilepsy is a neurological condition marked by frequent seizures and various cognitive and psychological effects. Reliable information is essential for effective treatment. Natural language processing models like ChatGPT are increasingly used in healthcare for information access and data analysis, making it crucial to assess their accuracy. This study aimed to investigate the accuracy of ChatGPT in providing educational information related to epilepsy. We compared the answers from ChatGPT-4 and ChatGPT-3.5 to 57 common epilepsy questions based on the Korean Epilepsy Society's "Epilepsy Patient and Caregiver Guide." Two epileptologists reviewed the responses, with a third serving as an arbiter in cases of disagreement. Out of 57 questions, 40 responses from ChatGPT-4 had "sufficient educational value," 16 were "correct but inadequate," and one was "mixed with correct and incorrect" information. No answers were entirely incorrect. GPT-4 generally outperformed GPT-3.5 and was often on par with or better than the official guide. ChatGPT-4 shows promise as a tool for delivering reliable epilepsy-related information and could help alleviate the educational burden on healthcare professionals. Further research is needed to explore the benefits and limitations of using such models in medical contexts.

1 December 2020 in Sleep Medicine
Verified
Journal Article
Closed access
DKDae Jin Kim
Dae Jin Kim
SMSue Jean Mun
Sue Jean Mun
Choi Jeong SuChoi Jeong Su
Choi Jeong Su
JKJiyoung Kim
Jiyoung Kim
GLGha-Hyun Lee
Gha-Hyun Lee
JCJae Wook Cho
Jae Wook Cho

19 May 2022 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Closed access
HKHyo Jae Kim
Hyo Jae Kim
JJJi-Ye Jeon
Ji-Ye Jeon
HKHyun-Woo Kim
Hyun-Woo Kim
SLSang-Ahm Lee
Sang-Ahm Lee

JLJung Hwa Lim
Jung Hwa Lim
JLJae-Hyok Lee
Jae-Hyok Lee
Chan-Young KwonChan-Young Kwon
Chan-Young Kwon
SLSang-Hyup Lee
Sang-Hyup Lee
CKChang-Wan Kang
Chang-Wan Kang
BKBo-Kyung Kim
Bo-Kyung Kim
Insomnia is a common health problem that can lead to various diseases and negatively impact quality of life. Pharmacopuncture is a new type of acupuncture that involves applying herbal medicine extracts to acupoints. Korean medicine doctors frequently use it to treat insomnia disorder. However, there is insufficient evidence to support the effectiveness and safety of pharmacopuncture for insomnia disorder. We designed a pragmatic randomized controlled trial to compare the effectiveness of pharmacopuncture and acupuncture for insomnia disorder. This multi-site, randomized, acupuncture-controlled trial will enroll 138 insomnia patients. The subjects will be randomly assigned to one of two groups, pharmacopuncture or acupuncture, at a 2:1 ratio. For 4 weeks, the participants will receive ten sessions of pharmacopuncture or acupuncture treatment and will be followed up for 4 weeks after the treatment ends. The Pittsburgh Sleep Quality Index score is the primary outcome measure. Insomnia severity index score, sleep parameters recorded using actigraphy and sleep diaries, physical symptoms associated with insomnia, emotions, quality of life, medical costs, and safety are the secondary outcome measures. The findings of this trial willprovide evidence that will be useful in clinical decision-making for insomnia treatment strategies.

1 August 2023 in Journal of Sleep Medicine
Verified
Journal Article
Open access
PDF file
JCJae Wook Cho
Jae Wook Cho
HKHyun-Woo Kim
Hyun-Woo Kim
JJJake Jeong
Jake Jeong
Kwangyeol BaekKwangyeol Baek
Kwangyeol Baek
Insomnia is a prevalent sleep disorder characterized by difficulties in falling asleep, frequent awakenings, or waking up too early. These disturbances adversely affect patient’s health. Although numerous insomnia treatment guidelines recommend cognitive behavioral therapy for insomnia (CBT-I) as the primary treatment approach, its clinical effectiveness has been hampered because of challenges such as insurance concerns, limited healthcare accessibility, inadequate compensation for providers, and a shortage of specialists. To address these limitations, CBT-I should be implemented as a digital therapeutic modality. Internationally, products such as Somryst, Sleepio, CBT-I Coach, Night Owl-Sleep Coach, and Minddistrict have been utilized. In South Korea, emerging digital therapeutic devices such as Somzz and PilLow Rx are also being introduced. In this review, we explored the current status of digital therapeutic modalities for insomnia in both international and domestic markets, aiming to provide insights into the future prospects in the realm of insomnia treatment in the modern digital healthcare era.

20 June 2024 in Asian Journal of Psychiatry
Verified
Journal Article
Closed access
SHSeongbeen Hwang
Seongbeen Hwang
JJJinyoung Jung
Jinyoung Jung
HMHyunoh Moon
Hyunoh Moon
DKDai Sik Ko
Dai Sik Ko
HKHyun-Woo Kim
Hyun-Woo Kim
YKYun Hak Kim
Yun Hak Kim